Restore your heart-body-brain balance for optimal health
Walsh Protocol · Biochemical Subtype
Copper imbalance (copper deficiency or overload) is one of the most commonly missed contributors to anxiety, mood instability, migraines, and hormonal dysregulation in clinical practice. The reason it’s missed: standard blood tests measure total copper, not the free copper that actually causes problems.
Copper imbalance can run in two directions — and they require different treatment approaches. Understanding which one applies requires testing. Guessing based on symptoms alone is not reliable because some symptoms overlap and the mechanisms are different.
Too much free copper in circulation, or an imbalanced copper-to-zinc ratio. The most common presentation in clinical practice. Standard blood copper can appear normal — what matters is the ratio of free copper to ceruloplasmin-bound copper, and the copper-to-zinc balance. Produces anxiety, hyperactivity, explosiveness, migraines, and hormonal symptoms.
Actually low copper — less common but clinically significant. Produces fatigue, anemia that doesn’t respond to iron, frequent infections, poor wound healing, and neurological symptoms. Zinc supplementation can be a culprit in rare cases according to Dr. Walsh. But vitamin E, molybdenum and possibly other metals can weaken absorption.
Copper and zinc are part of the same biochemical system and need to be evaluated together. These biochemical patterns are part of the Walsh clinical framework and are not formal psychiatric diagnoses. Copper imbalance is one of five major subtypes identified in the Walsh Protocol:
The body needs copper. It is an essential trace mineral with functions across multiple systems — which is precisely why imbalance in either direction creates such wide-ranging symptoms.
Copper helps maintain the correct shape of red blood cells and assists the body in absorbing iron. A copper deficiency can produce anemia even when iron levels are adequate — the iron is present but can’t be used effectively without sufficient copper. Copper supports immune function, helping create the reactive oxygen species that kill pathogens. It contributes to energy production, nerve health, connective tissue integrity, and bone strength.
In the nervous system, copper plays a specific and clinically important role: it is a cofactor in the conversion of dopamine into norepinephrine. This is where excess free copper becomes a significant problem. When copper is present in excess and unbound — not adequately controlled by ceruloplasmin or balanced by zinc — it operates as a powerful oxidative agent. Free copper will damage virtually every cell it encounters.
When I first started practicing the Walsh Protocol, I underestimated how common copper overload was. Conventional medicine teaches that elevated copper is rare and dramatic — acute copper toxicity produces nausea, vomiting, organ damage. That’s accurate for severe acute cases. But a subtler form of copper accumulation is far more common than conventional medicine recognizes.
Elevated copper isn’t just elevated serum copper, but as an imbalance between free and bound copper, or between copper and zinc. The critical numbers are a free copper percentage of above 20% and a copper-to-zinc ratio between 0.8 and 1.0. Standard labs don’t routinely calculate either.
People with copper overload may tend toward hyperactivity, anxiety, and explosiveness. The copper-dopamine-norepinephrine pathway explains much of this — excess free copper drives excess norepinephrine, producing the stimulated, reactive state that characterizes the clinical picture.
Testing is necessary to confirm this. Several other Walsh subtypes can produce similar presentations, and treatment differs significantly by subtype. Without testing there’s no reliable way to distinguish them.
Copper overload can present across a wide range of physical and psychological symptoms. Effects can be mild, moderate, or severe. Most patients present with a subset of these rather than the complete picture.
Copper deficiency is less common than copper overload but clinically significant and worth distinguishing. Because copper and zinc work in opposition, copper deficiency sometimes results from aggressive copper reduction protocols or high-dose unsupervised zinc supplementation — which is one reason clinical oversight matters for both conditions.
Copper deficiency symptoms are distinct from overload and include:
The overlap between some deficiency and overload symptoms — fatigue, neurological sensitivity, immune vulnerability — is why testing rather than symptomatic guessing is the only reliable approach to copper evaluation.
Estrogen stimulates copper retention in the body. Women with genetic variants in copper transport or ceruloplasmin function are particularly vulnerable during periods of significant hormonal change. This is one of the more clinically reliable indicators of copper overload:
Problems often begin at puberty — the onset of estrogen production coincides with the first accumulation of copper. Mood instability, anxiety, or behavioral changes at puberty in girls can reflect this mechanism.
Pregnancy is a paradox — copper accumulates significantly during pregnancy, yet many women feel better during pregnancy. The explanation: the developing fetus draws copper through the placenta, reducing the mother’s free copper load. Mood crashes in the weeks following delivery (postpartum depression) can reflect the rapid redistribution of copper as this draw ends.
Symptoms worsen with estrogen exposure — birth control pills, hormone replacement therapy, and perimenopause can all drive copper accumulation. Estrogen intolerance is a reliable clinical indicator worth pursuing with testing.
Menopause brings change in both directions — as estrogen drops, copper retention may decrease, but the years of accumulated copper can produce a different presentation. Evaluation at menopause is worth considering for women with a long history of relevant symptoms.
Testing requires a blood panel — not just a serum copper level. Serum copper alone tells you how much copper is present. What matters clinically is how much is free and how it relates to zinc. The full panel includes:
Total copper in the blood. Often within normal range even in functional overload. The starting point, not the conclusion.
The protein that binds and neutralizes copper. Combined with serum copper, allows calculation of free copper percentage. The critical measure is keeping free copper below 20% of total.
The copper-to-zinc ratio — target range 0.8 to 1.0 — is often more clinically meaningful than either value alone. Zinc and copper are adversarial; restoring zinc is frequently the primary treatment lever.
Included as part of the full Walsh panel to evaluate methylation status, which often co-exists with copper imbalance and influences treatment decisions.
Testing can be coordinated remotely for patients outside Hawaii through Dr. Gil’s telemedicine services. Results are interpreted in the context of clinical history and symptoms — not in isolation from the presentation.
For copper overload: The primary therapeutic approach is restoring the copper-zinc balance. Molybdenum and Vitamin E are the main “chelators” of copper.. The specific protocol is based on lab results and adjusted over time as retesting confirms the direction of change.
I’ve seen migraines, Meniere’s disease, anxiety, and fibromyalgia improve meaningfully with copper rebalancing. The timeline varies — some patients notice changes within weeks, others require several months of consistent protocol. Retesting at three to six months is standard.
For copper deficiency: Copper supplementation in the appropriate form and dose. This requires confirmed deficiency on testing — supplementing copper in someone with overload would worsen their condition significantly.
Why clinical oversight matters: High-dose zinc supplementation without monitoring can suppress copper levels into deficiency. The therapeutic window requires tracking. This is not a protocol to manage independently — the same intervention that resolves overload can cause deficiency if pushed too far without retesting.
Copper imbalance rarely exists in isolation. Many patients with copper overload also have pyroluria, methylation variants, or other Walsh subtypes operating simultaneously. The full panel evaluates the biochemical picture as a whole — not one subtype in isolation — which is why treatment protocols vary considerably between individuals presenting with similar symptoms.
Copper evaluation is often part of the clinical workup for patients in the Restore track. Biochemical stabilization — including copper-zinc rebalancing — is foundational to nervous system regulation. A system running on excess free copper cannot regulate effectively regardless of other interventions.
For patients doing pattern-level work, copper imbalance can be the physiological driver that explains why that work hasn’t held. When the body is under chronic oxidative stress from free copper, the nervous system’s capacity to integrate change is compromised. Addressing the biochemistry clears the way.
The first step is a clinical consultation. Dr. Gil will review your history and symptoms, determine whether testing is indicated, and outline a clear path forward. Testing can be coordinated remotely across most of the United States.
808-726-2772 · info@askdrgil.com · Hawaii & telemedicine